Skip to Content

WPI 3385 (Bupropion Hydrochloride Extended-Release (SR) 200 mg)

Pill with imprint WPI 3385 is White, Round and has been identified as Bupropion Hydrochloride Extended-Release (SR) 200 mg. It is supplied by Watson Pharmaceuticals.

Bupropion is used in the treatment of major depressive disorder; depression; smoking cessation; seasonal affective disorder and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3385

Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385  Front
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385  Back
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385

Bupropion Hydrochloride Extended-Release (SR)

Imprint
WPI 3385
Strength
200 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous antidepressants, Smoking cessation agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3385

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.